Skip to main content
Clinical Trials/NCT01645137
NCT01645137
Completed
Not Applicable

Effectiveness Of Osteopathic Manipulative Treatment In Neonatal Intensive Care Units: A Multicenter Randomized Clinical Trial

European Institute for Evidence Based Osteopathic Medicine3 sites in 1 country690 target enrollmentJuly 2012
ConditionsPrematurity

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prematurity
Sponsor
European Institute for Evidence Based Osteopathic Medicine
Enrollment
690
Locations
3
Primary Endpoint
Number of days of LOS
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

The use of complementary and alternative medicine in neonatal ward has been steadily rising during the last decade. This integrated medicine approach has been shown to be helpful to improve neonatal health care. Osteopathic manipulative treatment (OMT) has been applied to premature infants to reduce the length of stay and to cope with clinical complications. Results from previous studies documented the positive association between OMT and shorter period of hospitalisation as well as improvement of clinical conditions. The aim of this nationwide multicenter study is to demonstrate the effect of OMT on length of stay (LOS) in premature infants across 3 neonatal intensive care units (NICU).

Registry
clinicaltrials.gov
Start Date
July 2012
End Date
October 2013
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
European Institute for Evidence Based Osteopathic Medicine
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • preterm infants born at age between 29 and 37 weeks
  • osteopathic treatment performed \< 14 days after birth
  • preterms born in the same hospital

Exclusion Criteria

  • Gestational age \< 29 weeks
  • Gestational age \> 37 weeks
  • First OMT performed after 14 days from birth
  • genetic disorders
  • congenital disorders
  • cardiovascular abnormalities
  • proven or suspected necrotized enterocolitis with or without gastrointestinal perforation
  • proven or suspected abdominal obstruction
  • pre/post surgery patients
  • pneumoperitoneum

Outcomes

Primary Outcomes

Number of days of LOS

Time Frame: participants will be followed for the duration of hospital stay, an expected average of 4 weeks

Secondary Outcomes

  • pre-post difference in weight gain(participants will be followed for the duration of hospital stay, an expected average of 4 weeks)
  • number of episodes of vomit(participants will be followed for the duration of hospital stay, an expected average of 4 weeks)
  • days to full enteral feeding(participants will be followed for the duration of hospital stay, an expected average of 4 weeks)
  • NICU costs(participants will be followed for the duration of hospital stay, an expected average of 4 weeks)
  • number of episodes of regurgitation(participants will be followed for the duration of hospital stay, an expected average of 4 weeks)
  • number of episodes of stooling(participants will be followed for the duration of hospital stay, an expected average of 4 weeks)

Study Sites (3)

Loading locations...

Similar Trials